论文部分内容阅读
应用抗RSV-ADV-I-RNA治疗病毒性肺炎33例,治疗前、后血清特异性抗体水平明显增高,差异有显著意义。对照组治疗前、后无显著差异,提示,抗RSV-ADV-I-RNA可提高患儿自身抗病毒能力,为应用本药治疗病毒性肺炎取得较好疗效提供了理论依据。
Application of anti-RSV-ADV-I-RNA in the treatment of viral pneumonia in 33 cases before and after treatment serum-specific antibody levels were significantly increased, the difference was significant. The control group before and after treatment showed no significant difference, suggesting that anti-RSV-ADV-I-RNA can improve children’s own anti-virus ability for the treatment of viral pneumonia with good efficacy to provide a theoretical basis.